Sandbox/0319: Difference between revisions
< Sandbox
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
! style="font-size: 100%; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" | {{fontcolor|#F8F8FF|FDA-Labeled Use}} | ! style="font-size: 100%; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" | {{fontcolor|#F8F8FF|FDA-Labeled Use}} | ||
|- | |- | ||
! style="padding: 0 5px; font-size: 90%; background: #6D9CC9; border-radius: 5px 5px 5px 5px;" | | ! style="padding: 0 5px; font-size: 90%; background: #6D9CC9; border-radius: 5px 5px 5px 5px;" | <div class="mw-customtoggle-rx01" style="cursor: pointer; -webkit-user-select: none; text-align: left; color: #F8F8FF;">Prophylaxis of Ischemic Complications in Unstable Angina and Non-Q-Wave Myocardial Infarction</div><div class="mw-collapsible mw-collapsed" id="mw-customcollapsible-rx01" style="text-align: left; color: #F8F8FF;"> ▸ Fragmin injection 120 IU/kg SC q12h (≤10000 IU)</div> | ||
|- | |- | ||
! style="padding: 0 5px; font-size: 90%; background: #6D9CC9; border-radius: 5px 5px 5px 5px;" | {{fontcolor|#F8F8FF|Prophylaxis of Venous Thromboembolism Following Abdominal Surgery}} | ! style="padding: 0 5px; font-size: 90%; background: #6D9CC9; border-radius: 5px 5px 5px 5px;" | {{fontcolor|#F8F8FF|Prophylaxis of Venous Thromboembolism Following Abdominal Surgery}} | ||
|- | |- | ||
| style="padding: 0 5px; font-size: 90%; background: # | | style="padding: 0 5px; font-size: 90%; background: #104E8B; border-radius: 5px 5px 5px 5px;" align=left | {{fontcolor|#F8F8FF|▸ 456}} | ||
|- | |- | ||
|} | |} | ||
Revision as of 15:58, 19 March 2014
| FDA-Labeled Use |
|---|
Prophylaxis of Ischemic Complications in Unstable Angina and Non-Q-Wave Myocardial Infarction ▸ Fragmin injection 120 IU/kg SC q12h (≤10000 IU)
|
| Prophylaxis of Venous Thromboembolism Following Abdominal Surgery |
| ▸ 456 |